(Q57072093)

English

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

scholarly article by C. A. Akdis et al published August 2006 in Allergy

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

atopic dermatitis

1 reference

based on heuristic

inferred from title

Philippe Eigenmann

object named as

P. Eigenmann

6

0 references

Stephan Weidinger

object named as

S. Weidinger

21

0 references

Jonathan M. Spergel

object named as

J. Spergel

18

0 references

Carsten Bindslev-Jensen

object named as

C. Bindslev-Jensen

4

0 references

Torsten Zuberbier

23

object named as

T. Zuberbier

0 references

Thomas Platts-Mills

14

object named as

T. A. E. Platts-Mills

0 references

F. Estelle R. Simons

17

object named as

F. E. R. Simons

0 references

author name string

C. A. Akdis

1

0 references

M. Akdis

2

0 references

T. Bieber

3

0 references

M. Boguniewicz

5

0 references

Q. Hamid

7

0 references

A. Kapp

8

0 references

D. Y. M. Leung

9

0 references

J. Lipozencic

10

0 references

T. A. Luger

11

0 references

A. Muraro

12

0 references

N. Novak

13

0 references

L. Rosenwasser

15

0 references

A. Scheynius

16

0 references

K. Turjanmaa

19

0 references

U. Wahn

20

0 references

T. Werfel

22

0 references

publication date

August 2006

0 references

0 references

61

0 references

8

0 references

969-987

0 references

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The natural course of atopic dermatitis from birth to age 7 years and the association with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The genetics of atopic dermatitis: recent findings and future options.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Association of NOD1 polymorphisms with atopic eczema and related phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Association study of mast cell chymase polymorphisms with atopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Effect of breast-feeding on the development of atopic dermatitis during the first 3 years of life--results from the GINI-birth cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Prevention of atopic eczema. Evidence based guidelines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: avoidance of indoor allergens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Prevalence of IgE-mediated food allergy among children with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Factors associated with the development of peanut allergy in childhood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Immune mechanisms leading to atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Allergic and nonallergic forms of atopic diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Atopic eczema/dermatitis syndrome and Malassezia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Natural history of "intrinsic" atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Apoptosis in tissue inflammation and allergic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Regulatory T cells control the development of allergic disease and asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

T regulatory cells in atopic dermatitis and subversion of their activity by superantigens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of β-defensins, LL37, and TLR2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Eosinophils and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

IL-31: a new link between T cells and pruritus in atopic skin inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Update on food allergy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Infection in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Cathelicidin deficiency predisposes to eczema herpeticum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Pityrosporum species as a cause of allergy and infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Role of regulatory T cells in human diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Late eczematous reactions to food in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Utility of food-specific IgE concentrations in predicting symptomatic food allergy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Role of mild cleansing in the management of patient skin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Food allergy--accurately identifying clinical reactivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Corneometric, sebumetric and TEWL measurements following the cleaning of atopic skin with a urea emulsion versus a detergent cleanser

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Position paper on diagnosis and treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

First experience of topical SDZ ASM 981 in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Bacterial infections and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Frequency of sensitization to antimicrobials in patients with atopic eczema compared with nonatopic individuals: analysis of multicentre surveillance data, 1995-1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Resistance of Staphylococcus aureus to fusidic acid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Secondary infections in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Systemic ketoconazole for yeast allergic patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Framing the future of antifungals in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Cyclosporine in severe childhood atopic dermatitis: a multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The treatment of atopic dermatitis with systemic immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Guidelines for prescribing azathioprine in dermatology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Azathioprine in dermatology: a survey of current practice in the U.K.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Azathioprine for atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Retrospective review of the use of azathioprine in severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Guidelines for the management of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Phototherapy of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: improvement through parent insight and education

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Does breastfeeding protect against allergic rhinitis during childhood? A meta-analysis of prospective studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Probiotics in the management of atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

A comparison between criteria for diagnosing atopic eczema in infants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01153.X

21 January 2018

Identifiers

10.1111/J.1398-9995.2006.01153.X

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57072093&oldid=2140898692"